Transcription factors are commonly involved in leukemia by activation through chromosomal translocations and normally function in cell type(s) that differ from that of the tumor. TAL2 is a member of a basic helix-loop-helix gene family specifically involved in T cell leukemogenesis. Null mutations of Tal2 have been made in mice to determine its function during development. Tal2 null mutant mice show no obvious defects of hematopoiesis. During embryogenesis, Tal2 expression is restricted to the developing midbrain, dorsal diencephalon, and rostroventral diencephalic/telencephalic boundary, partly along presumptive developing fiber tracts. The null mutant mice are viable at birth but growth become progressively retarded and they do not survive to reproductive age. Tal2-deficient mice show a distinct dysgenesis of the midbrain tectum. Due to loss of superficial gray and optical layers, the superior colliculus is reduced in size and the inferior colliculus is abnormally rounded and protruding. Death is most likely due to progressive hydrocephalus which appears to be caused by obstruction of the foramen of Monro (the connection between the ventricles of the forebrain). Thus, in addition to its oncogenicity when ectopically expressed, Tal2 normally plays a pivotal role in brain development and without this gene, mice cannot survive to maturity.
INTRODUCTION
Chromosomal translocations have not only yielded a plethora of new oncogenes which have tissue-specific tropism in tumorigenesis but also have been a source of important new transcription factors which are often associated with specific developmental processes in their normal sites of expression (Rabbitts, 1994) . Various members of the basic helix-loop-helix (bHLH) gene family have been found at the junctions of chromosomal translocations. This family of proteins plays a role in normal development by both protein-protein interaction and by protein-DNA interactions, for example, in hematopoiesis and vasculogenesis (Tal1, also called Scl), myogenesis (myoD, myogenin), development of the neuroendocrine system (sim1), and retina (Nabeshima et al., 1993; Robb et al., 1995 Robb et al., , 1996 Porcher et al., 1996; Michaud et al., 1998; Cepko, 1999) . The TAL family of bHLH genes has three known members (LYL1, TAL1, and TAL2), each of which is activated by chromosomal translocations associated with T cell acute lymphoblastic leukemia (Baer, 1993) . Indeed, TAL1 is malignantly activated in most cases of pediatric T-ALL, even in the absence of a chromosomal translocation (Bash et al., 1995) . Given the striking sequence homology between their respective bHLH domains, it is likely that TAL1, TAL2, and LYL1 promote tumorigenesis by a common mechanism. All three proteins dimerize with members of the class A subgroup of bHLH protein (i.e., E47, E12, E2-2, and HEB) (Hsu et al., 1991 (Hsu et al., , 1994 Xia et al., 1994; Miyamoto et al., 1996) , as well as the leukemogenic LIM-only proteins, LMO1 and LMO2 (Valge-Archer et al., 1994; Wadman et al., 1994 Wadman et al., , 1997 . Tal1-Lmo2 interactions appear to play a role in tumorigenesis as tumor occurrence in transgenic mice coexpressing Tal1 and Lmo2 have an increased tumor incidence (Larson et al., 1996) .
The TAL2 gene is activated in the chromosomal translocation t(7;9) (q35;q34) in a subset of T-ALL patients (Reynolds et al., 1987; Westbrook et al., 1987; Tycko et al., 1989; Xia et al., 1991) , causing enforced TAL2 expression in the T cell lineage. Previously normal Tal2 expression had been described in adult testes (Xia et al., 1991) and using in situ hybridization revealed expression of the gene in the developing midbrain, diencephalon, and anterior pons (Mori et al., 1999) . These studies raise questions about Tal2 function in brain development. In addition, as TAL2-associated chromosomal translocations have only been found in T cell tumors, it seemed possible that TAL2 might also have a role in normal hematopoiesis. Therefore, null mutation of the mouse Tal2 gene was made by homologous recombination to investigate the role of Tal2 in mouse development. Mice homozygous for this mutation have no obvious defect of hematopoiesis. Instead we observed early postnatal lethality coinciding with a progressive hydrocephalus that developed due to obstruction of the foramen of Monro. In addition dysgenesis of the midbrain tectum occurred. Thus Tal2 plays a pivotal role in development of the mature central nervous system.
MATERIALS AND METHODS

Construction of the Targeting Vector
Genomic DNA clones of mouse Tal2 were isolated by screening a 2001 library of strain 129-derived E14 TG2a ES cell DNA by hybridization with T3.1B2S, a genomic DNA fragment that contains coding sequences of human TAL2 (Xia et al., 1991) . A 10.2-kb HindII-EcoRI fragment of Tal2 DNA (see Fig. 1 ) was subcloned into the pBluescript-KS plasmid vector (Stratagene). A 0.8-kb BglII-SmaI fragment containing coding sequences for the C-terminal 103 residues of the 108 amino acid Tal2 polypeptide was removed and replaced with a 5.0-kb fragment containing the lacZ and MC1-neo cassettes (Thomas and Capecchi, 1987) . The final targeting construct was generated by placing a 1.8-kb MC1-tk cassette adjacent to the 3Ј-end of the subcloned Tal2 genomic DNA.
Gene Targeting and Genomic Analysis
The targeting construct was linearized at a unique SalI site prior to electroporation of the E14 or CCB line of ES cells. ES cells in which homologous recombination had occurred were selected in G418 and gancyclovir (Thomas and Capecchi, 1987) and DNA was analyzed by filter hybridization as described (LeFranc et al., 1986) using 5Ј (pBWBH) and 3Ј (pTal2HH) external probes (Fig. 1) . A single insertion by homologous recombination was confirmed with a neomycin probe. Two independent targeted clones (designated Tal2/1 from E14 and Tal2/64 from CCB ES cells) were studied.
These were injected into C57Bl6 blastocysts and the male chimeric mice obtained were crossed with C57Bl6 females to produce germline carriers of the mutations. These heterozygous mice were normal. Crossing heterozygous animals produced homozygous offspring for analysis. For genotype analysis, genomic DNA was screened by PCR using a primer pair specific to the targeted allele in parallel with a wild-type allele-specific primer pair. Conditions of PCR were 35 cycles of a touchdown PCR program (Don et al., 1991) (annealing temperature decreasing from 65 to 55°C): (a) targeted allele specific, PCR product size 240 bp, PAF1 5Ј TCG CCT TCT ATC GCC TTC and Tal2B2 5Ј CAT AAT CCT CAC TGC TCT GCT CCA; and (b) wild-type allele specific, PCR product size 300 bp, Tal2F AAG CTT TAG TCA AAA TGA ATT TCC and Tal2B GAT ATA CCT CAT TGC CAA GCG AAG.
Histology and Determination of Tal2 Expression
X-gal staining during development was carried out essentially as described (Allen et al., 1988) to reveal lac expression. Embryos (E9.5-12.5) were immersion fixed in fresh 4% paraformaldehyde (PFA)-phosphate-buffered saline (PBS). Duration of fixation was depending on size (E9.5/30min, E12.5/45min). For embryonal stages older than E12.5, 0.3% NP-40 was added to the fixation and washing solutions. Whole-mount immersion staining was performed, after washing in PBS, in the staining solution (0.2% X-gal, 2 mM MgCl 2 , 5 mM 3H 2 O, 5 mMK 3 Fe(CN) 6 ). For stage E16.5, the brain was dissected from the surrounding tissue and fixed for 1 h, equilibrated in 30% sucrose-PBS. Sixty-micrometer cryosections were cut on a sliding microtome and X-gal stained thereafter. Sections were postfixed after staining in 4% PFA and counterstained with neutral red. Postnatal animals younger than 10 days were killed with an intraperitoneal lethal injection of Euthanol, and brains were dissected and immersion fixed overnight in 4% PFA. Older animals were killed with an intraperitoneal lethal injection, gravity perfused (⌬h 70 cm) with 4% PFA, and postfixed for 4 h. All brains were equilibrated in 30% sucrose before sectioning on a freezing stage microtome at 40 m. Separate series of sections (1:6) were mounted on glass slides and stained with cresyl violet or stained for acetylcholinesterase activity by the thiocholine reaction, using 0.01% ethoproprazine to inhibit nonspecific esterases and 0.25% silver nitrate to enhance the sulfide reaction product.
Flow Cytometric Analysis of Cell Surface Marker Expression
Single-cell suspensions were prepared from mouse thymus, spleen, and bone marrow. One-hundred microliters of cells (5 ϫ 10 7 /ml) was incubated at 4°C for 20 min in PBS with 5% fetal calf serum (FCS) with the following antibodies: CD4, CD8, CD25, CD44, Ter119, B22O, and Thy1. Antibodies (PharMingen) were conjugated with either fluorescein isothiocyanate (FITC) or phycoerythrin (PE). Isotype-matched fluoresceinated antibodies were used as controls for nonspecific immunofluorescence. After antibody labeling, cells were washed once with PBS containing 5% FCS and resuspended in 1 ml of PBS/5% FCS. Flow cytometric analysis was performed using a FACScalibur (Becton Dickinson, San Jose, CA) and analyzed with Cell Quest software (Becton Dickinson).
RESULTS
Null Mutation of Tal2 Results in Postnatal Lethality
The 108 codons that specify the full-length Tal2 protein are contained within a single exon of the mouse Tal2 gene (Fig. 1A) . A null allele of Tal2 was made in ES cells using a targeting vector in which the sequences for the codons 7-108 were replaced with the bacterial ␤-galactosidase (lacZ) gene (Fig 1B) . In addition, the MC1-neo cassette (Thomas and Capecchi, 1987) was introduced as a selectable marker. Homologous recombination was carried out in two (pTal2HH) is indicated above the restriction map of Tal2. The coding exon is denoted by the box; within this exon, the Tal2 coding sequences (324 bp) are represented by a closed box, and the 3Ј-untranslated sequences (ϳ3.6 kb) by a shaded box. (B) The replacement vector used for targeting Tal2. A deletion was introduced into the Tal2 exon coincident with the insertion of a cassette carrying the lacZ and MC1-neo genes (the latter providing selection for targeted clones). The MC1-tk cassette (Thomas and Capecchi, 1987) was added at the 3Ј end of the vector for negative selection of nonhomologous integration. Within the replacement vector, the hatched box indicates the position of the MC1-tk cassette and the dashed line represents sequences of the pBluescript vector (pBS). Horizontal arrows indicate the direction of transcription of the lacZ, MC1-neo, and MC1-tk cassettes. (C) The predicted structure of the targeted Tal2 allele following homologous recombination. Only relevant restriction sites are shown. The expected lengths of the recombined XbaI (17.5 kb) and SacI (10 kb) restriction fragments diagnostic of homologous recombination are shown. Enzymes: B, BamHI; H3, HindIII; R, EcoRI; B2, BglII; Sm, SmaI, S, SacI; Sl, SalI, Xb, XbaI. (D) Filter hybridization of genomic DNA from a litter of a Tal2 heterozygous cross compared with nontargeted ES cell DNA (CCB). DNA was digested with XbaI or SacI, fractionated on 0.8% agarose, and transferred to nylon membrane followed by hybridization with the 5Ј (pBWBH) or 3Ј (Tal2HH) Tal2 probes or a neomycin probe as shown. The bands corresponding to targeted alleles are present in mice 1, 2, and 4 (heterozygous mice); each of these mice also has a single band that hybridizes with the neomycin probe, corresponding to the homologous recombination site. Sizes were estimated by coelectrophoresis of phage DNA cleaved with HindIII.
ES lines (E14 and CCB), which gave similar results when mice were generated after injection of the targeted ES cells into blastocysts and germline transmission was obtained. The presence of a targeted allele in the germline of mice was initially determined by filter hybridization using probes flanking both sides of the targeting segment and with the neomycin gene to confirm the presence of a single event (Figs. 1C and 1D ).
Once germline transmission was obtained, heterozygous carriers were interbred to produce homozygous offspring. In excess of 200 mice were analyzed at the time of weaning but no homozygous mice were found. However, homozygous pups were found in newborn litters, indicating that the Tal2 mutation causes lethality between birth and adult stages. At birth, Tal2 null mutant mice were macroscopically indistinguishable from their heterozygous and wildtype littermates. After 10 -12 days, however, growth retardation became obvious (Fig. 2B) , with weight loss beginning as early as day 6. The animals showed no signs of illness and remained active and their feeding and drinking behavior appeared normal, although there were occasional periods of decreased activity and convulsions have been observed. Forty percent of the null mutant mice died between 21 and 24 days after birth and all had died by 32 days (Fig. 2) . Heterozygous mice in were in all respects asymptomatic and indistinguishable from wild-type mice. Postmortem examination of thymus, heart, lung, spleen, liver, kidneys, periadrenal gland, pancreas, and bone marrow (femur) of the deceased Ϫ/Ϫ animals showed no detectable abnormalities. In addition, blood chemistries were analyzed (sodium, calcium, potassium, glucose, urea, creatinine) from Tal2 null mutant mice (at days 15-17) but no significant differences were found when compared to their wild-type or heterozygous littermates (data not shown). These findings show that Tal2 homozygous mutant mice cannot survive to maturity.
Hematopoiesis Seems Unaffected by Homozygous Tal2 Null Mutation
As Tal2 is a T cell oncogene, it was possible that a defect of hematopoiesis might account for the premature death of homozygous mice. We examined the cell populations of thymus, spleen, and bone marrow from three homozygous Tal2 mutant mice and one wild-type mouse at 16 days of age. Cell surface marker expression of T cells (CD4 and CD8; CD25 and CD44), B cells (B220), myeloid cells (Mac-1 and Gr-1), and progenitors (Ter119, Thy1) was examined. There was no evidence of any disparity between Tal2 mutant mice and the wild-type expression pattern (data not shown). Thus, while we cannot completely rule out small changes in the various hematopoietic populations, the data are consistent with the view that Tal2 null mutation does not affect hematopoiesis.
Tal2 Expression in CNS Development
As there was no evidence that hematopoiesis was influenced by lack of Tal2 protein, we examined Tal2 expression
FIG. 2. Survival of Tal2 homozygous null pups after birth.
Heterozygous Tal2 mice were mated and litters were analyzed by tail blotting or PCR for the presence of the targeted allele after 35 days. Pups that died between birth and 35 days were genotyped. (A) Graph showing the time of death of null mutant mice. A total number of 27 litters from heterozygous crossings were studied and counted daily. The time of death of 50 confirmed Tal2 null mutant mice derived from two different ES clones (25 clone 1, 25 clone 64) is shown. 40% of the null mutant mice died between day 21 and day 24 after birth. No null mutant mice were found to survive for more than 32 days. (B) Photograph showing size difference between Tal2 null mutant mouse (weighing 5.7 g) and wild-type littermate (weighing 9 g) at day 15. At birth, Tal2 null mutant mice are indistinguishable from their heterozygous and wild-type littermates. Between day 15 and day 17, however, the average null mutant mouse is 44% lighter than its average littermate. patterns to determine a site which might be relevant to the phenotype observed. Tal2 expression has been found in neural tissue using in situ hybridization (Mori et al., 1999) . Since the targeting event had fused the lacZ gene to the Tal2 coding exon, the presence of ␤-galactosidase could be used as a reporter for the Tal2 promoter activity. In order to elucidate the effect of Tal2 null mutation we examined the expression of Tal2 in embryonic development in stages E10.5, E11.5, E12.5, E16.5, P0, P5, and P15/17. Each stage was examined in between two and four litters (Ϫ/Ϫ, ϩ/Ϫ) and one wild type, using embryonic or postnatal pups. The expression pattern of lacZ was determined in heterozygous mice ) and compared to expression in Tal2 null mutant mice to detect potential differences. However no differences have been found between the expression patterns between Tal2 ϩ/Ϫ and Ϫ/Ϫ mice. During development ␤-galactosidase activity was restricted to the developing brain, first being detected at E10.5 (Figs. 3A and 3B) confined to the ventrolateral mesencephalon (excluding the midline) and the ventral diencephalic/telencephalic boundary. ␤-Galactosidase expression in the ventrolateral mesencephalon intensified by about E11.5 and growth of ␤-galactosidase-positive axons could be observed projecting to the midbrain tectum (Fig. 3C ). In addition, two bilateral foci of strong ␤-galactosidase staining extended into the diencephalon. Dorsally, staining extended, parallel to the midline, into the presumptive posterior commissure and pretectum, but was not connected by commissural fibers at this stage. Ventrally, staining extended along the zona limitans intrathalamica (ZLI) into the ventrolateral diencephalon. This general ␤-galactosidase staining pattern in the midbrain and diencephalon intensified further and expanded somewhat by E12.5 (Figs. 4A and 4C ).
There is a striking expression of Tal2 in the developing fiber tracts (Fig. 4C) . The wave of commissural fibers, that cross the midline in the cranial midbrain at E11.5, extends caudally during E12 (Figs. 4C, 4E , and 4F). Dense commissural fiber tracts build up in the pretectum and posterior commissure (Figs. 4C and 4F-4H ). In addition we observed staining in axons extending from the ZLI to the dorsal midline (Fig. 4E) . The expression at the diencephalictelencephalic boundary remained relatively faint and was confined to two streaks in the ganglionic eminence (GE) joining in the optic recess (OR) (Figs. 4D and 4E ). Weak expression could be found in the mammillary region (Fig.  4H) .
␤-Galactosidase staining, corresponding to Tal2 expression, weakens after about E16, although some staining could still be observed in the equivalent regions to those of earlier stages (Figs. 4 and 5) . There was still intense ␤-galactosidase staining in the most caudal part of the midbrain but no expression in the developing hindbrain (Fig. 5A) . The midbrain tectum and posterior commissure still showed strong staining (Figs. 5C and 5D) and some weak staining was seen in the mammillary region. At this stage the ZLI has differentiated into the extramedullary lamina (EML), delineating the boundary between dorsal and ventral thalamus (Figs. 5B-5D ). We detected lacZ staining from the presumptive paraventricular nucleus of the hypothalamus to the lateral surface of the EML, which gives rise to the retinotectal tract and ventrolateral geniculate body (Fig. 5B) . From birth to P15 we can see decreasing staining in the midbrain tectum. We confirmed weak expression in the midbrain tectum at day 15 by RT-PCR and Northern filter hybridization analysis (data not shown).
Abnormal Midbrain Development in Tal2؊/؊ Mice
On the basis of Tal2 expression patterns, we examined the midbrain tectum of Tal2Ϫ/Ϫ mice. We could not detect any morphological changes during embryogenesis by comparing null mutant with heterozygous and wild-type mice. At P2, subtle differences in the midbrain tectum enabled us to identify the Tal2 knockout mice among their littermates. At P15 the dysgenesis of the midbrain tectum was obvious in all of the 23 null mutant animals examined (Fig.  6) . The superior colliculi were reduced in size and the inferior colliculi were abnormally rounded and protruding. Histological sections stained with cresyl violet or for acetylcholinesterase activity revealed that the layering in the superior colliculus was disrupted (Fig. 6 ).
In the null mutant mice, the superficial gray was hypoblastic and developed only in a rudimentary form. This can best be seen in the acetylcholinesterase (AchE) staining (Fig.  6 ). In this staining, the whole superficial gray is highly reactive due to AchE activity of intrinsic cells (Wallace and Fredens, 1988) . The optical layer is reduced in size and depth, as well as in lateral extension. The deep gray layer as well as the intermediate gray and white layers appear unchanged. The abnormalities in the two outer layers are likely to account for the macroscopically obvious dysgenesis/size reduction of the superior colliculus.
Postnatal Development of Hydrocephalus in Tal2 Null Mutant Mice
None of the observed expression patterns or distinct abnormalities found in brain development gave a clear possibility to explain the cause of death of the homozygous mutant animals. Nonetheless, it seems most likely that a brain defect was behind the premature lethality. Thus postmortem examination was carried on brains from perfused 16-day-old Tal2 homozygous null mutant mice and their littermates. This analysis revealed severe distortions of thalamic structures combined with drastic unilateral or bilateral enlargement of the lateral ventricles in all six histologically examined knockout mice (the degree of distortion varied from mouse to mouse) (Fig. 7 ). An additional six null mutant animals were macroscopically examined (using scalpel sections) and all of them showed a macroscopic hydrocephalus. This was consistently observed in Tal2 Ϫ/Ϫ mice but not in wild-type or heterozygous Tal2 mice. Hydrocephalus was present only in the lateral ventricles, whereas the third and fourth ventricles were never distended. The most likely explanation for such findings is obstruction at the level of the interventricular channel connecting the lateral and the third ventricles, known as the foramen of Monro. Consistent with this possibility, analysis of tissue sections showed uni-or bilateral compression of the fimbria fornix along the roof of the thalamus with complete obstruction of the foramen of Monro in all cases of hydrocephalus examined (Fig. 7) . Different postnatal stages (P2/3, P5, P8, P12-three null mutant mice and one wild-type mouse per stage) were histologically analyzed in order to detect time of onset of the hydrocephalus. Generally severity of these changes increased with age. The youngest animal in which we could clearly identify a hydrocephalus was 5 days old. The time of onset of the malformations is subject to some variation between individual mice. The most likely cause of death is therefore the hydrocephalus.
DISCUSSION
TAL2 encodes a bHLH transcription factor discovered because of its capability to contribute to T cell acute leukemia tumorigenesis when the gene is activated via a   FIG. 5 . Tal2 expression in brain at embryonic day 16.5. A heterozygous embryo from a Tal2/64 breeding was dissected at E16.5 and sections of the brain were stained for ␤-galactosidase after sectioning with a sliding microtome (60-m sections). The section in A is a parasagittal section of the whole brain stained with X-gal and indicating the levels at which the sections shown in B-D were taken. The staining in the parasagittal sections occurs along the presumptive extramedullary lamina (equivalent to ZLI in earlier stages), mammillary region (weak), and midbrain tectum. Note the difference in ␤-galactosidase expression between the caudal midbrain and the developing cerebellum. The coronal section in B shows X-gal staining in the presumptive extramedullary lamina (EML) delineating the border between dorsal and ventral thalamus. This structure may serve as path for tract formation such as mammillothalamic tract and retinotectal tract. The lateral part gives rise to the ventral lateral geniculate body. In addition, staining was found in the region of the fasciculus retroflexus (FR). (B-D) Coronal sections at the level of the posterior commissure (PC) and lateral habenula fibers. The expression in the EML extends from the lateral part surface of the thalamus to the paraventricular nucleus of the hypothalamus (pvh). Pl, pineal gland.
FIG. 6.
Abnormalities of superior and inferior colliculi in Tal2 homozygous mutant mice. Littermates from a cross between Tal2 heterozygous mutant animals were sacrificed at 15 days after birth and the brains were dissected for analysis. (A) Dorsal views of these brain preparations of wild-type (ϩ/ϩ), Tal2 heterozygous (ϩ/Ϫ), and Tal2 homozygous (Ϫ/Ϫ) animals. This comparison shows dysgenesis of the mesencephalic tectum in Tal2 Ϫ/Ϫ mice. Wild-type and heterozygous animals show a normal tectum, whereas in the null mutant mouse, both the superior and the inferior colliculi (SC and IC, respectively) show dysgenesis. The superior is reduced in size and the inferior chromosomal translocation (Xia et al., 1991) . The specific association with T cell tumors suggested that the gene might be expressed, and therefore functional, in hematopoiesis as it is thought that chromosomal translocations occur at open chromatin sites where gene transcription occurs. Such a function for TAL2 would not preclude more widespread functions, particularly in light of expression of the gene in mouse brain and testis (Xia et al., 1991; Mori et al., 1999) . Therefore, the function of the mouse Tal2 gene was investigated by creating null mutations by gene targeting. We could find no evidence of a hematopoietic defect in Tal2 null mutant mice using the criterion of surface marker expression compared to control mice. However, we observed that Tal2 function is essential for normal CNS development and survival.
Tal2 Function Is Required for Normal Midbrain Development
During embryogenesis, ␤-galactosidase levels, used as a reporter for Tal2 promoter activity, are high in the midbrain (Figs. 2 and 3 ) reflecting the activity of the Tal2 promoter. These expression levels taper off during embryonic development and very little ␤-galactosidase activity can be found after birth. The homozygous null mutant Tal2 mice are born and initially appear normal, but die between 13 and 32 days after having shown signs of runting. As a high degree of Tal2 expression occurs in the midbrain, we focused studies on the development of that region. We were intrigued by the discrepancy between time of Tal2 expression and occurrence of overt symptoms in the young Tal2 null mutant mice. Our strategy to elucidate the phenomenon was to examine and compare the ϩ/Ϫ and Ϫ/Ϫ mice during development, potentially enabling us to detect loss of X-gal-positive cells due to complete lack of wild-type Tal2 protein. The X-gal staining of the compared animals was identical by microscopic examination and no differences could be found.
During embryonic development we could not detect any malformations in Tal2 null mice compared with wild-type and heterozygous mice. However, considerable development of the midbrain takes place after birth, and we were able to observe subtle differences of the midbrain tectum morphology as early as day P2 which were sufficiently prominent to enable us to distinguish Tal2 null mice from their littermates. At P15, the abnormal morphology of the colliculus shows an abnormally rounded, protruding morphology. The abnormal layering is most prominent in sections stained for AchE activity. The superficial gray (SG) is hypoblastic and hardly visible in the Tal2 null mouse. In addition, the optical layer (OL)is reduced in thickness and in lateral extension. SC, superior colliculus; IC, inferior colliculus; CU, lobulus culmen Transverse sections are shown in B-J. (D, E, H, and J) Stained with cresyl violet; (B, C, F, and G) stained for acetylcholinesterase activity. SC, superior colliculus; IC, inferior colliculus; OL, optical layer; PG, paraaquiductal gray; SG, superficial gray; IG, inferior gray. Specimens from wild-type, heterozygous Tal2 mice or Tal2 null mice are indicated as ϩ/ϩ, ϩ/Ϫ, or Ϫ/Ϫ respectively. midbrain tectum in the null mutant mice was apparent, with the superior and inferior colliculus being distorted. The superior colliculus and the superficial gray layer play important roles in the visual pathways. The superficial gray receives input from nearly all retinal ganglion cells in topographic representation (Linden and Perry, 1983; Cheng et al., 1995; Drescher et al., 1995; Zhu and Julien, 1999) . The retinal axons enter through the optical layer and project to cells in the superficial gray and in turn send axons into deeper layers where other sensory systems are represented (Paxinos, 1995) .
We have observed relatively few, highly dispersed lacZpositive cells in the SC of ϩ/Ϫ and Ϫ/Ϫ in 16/17 mice. As the same pattern appears in ϩ/Ϫ and Ϫ/Ϫ mice, Tal2-expressing cells probably do not die. It is more likely that these cells simply get diluted by Tal2-negative cells as development proceeds. To exclude the possibility that the few remaining lacZ staining were not due to long-lived ␤-gal protein, we assessed the endogenous Tal2 expression in superior colliculi of wild-type mice at P16 by Northern analysis and by RT-PCR. While RT-PCR gave a positive signal, the Northern hybridization showed only a very weak Tal2 band. These data are consistent with the persistence of a few expressing cells at postnatal times P15/P17. There are several possible mechanisms by which postnatal defects can occur in the absence of widespread Tal2 expression at later time points. First, a subset of SC cells (normally Tal2 positive) may be needed for differentiation of Tal2-negative cell in the superficial gray (e.g., requiring signals by cell/cell contact during development or after birth, which are lacking in the Tal2 null mice). Second, an inherited abnormality may occur in previously Tal2-positive cells or their precursors and, third, a second gene may be spatially expressed and encode a protein which compensates for Tal2 functions up to its transcriptional silencing, only after which Tal2 null phenotype can be manifested.
Premature Death of Tal2 Null Mutant Mice
Expression studies described here using the lacZ knock-in approach and those using in situ hybridization (Mori et al., 1999) concur on the sites of Tal2 expression during embryogenesis. Neither study found evidence of extensive or substantial Tal2 expression after birth. The onset of runting and eventual premature death of Tal2 null mutant mice do not obviously correlate with Tal2 expression. At death, the null mutant mice show a prominent hydrocephalus. We found prominent distention of one or both lateral ventricles in the null mutant mice, in addition to the occlusion of the foramen of Monro and flattening of the surrounding fornix area in all animals, suggesting that an obstruction occurs at this point. At the time preceding the development of the hydrocephalus and in stages in which a hydrocephalus is overt in null mutant animals (P0 -P17), we could not find lacZ staining (either in the heterozygous or in the homozygous mice) in the vicinity of the foramen of Monro (carefully screened PO, P5, P14, P15/P17). However, earlier in embryonic development we observed ␤-galactosidase expression in the ventral diencephalon close to the diencephalic-telencephalic border and in the mammillary region. In this setting absence of Tal2 expression in null mutant mice in the rostral diencephalon, extending from the optic recess into the ganglionic eminence, in parallel with the developing foramen of Monro (Fig. 3) , may lead to obstruction and thus to hydrocephalus. Hydrocephalus, with compression of vital CNS structures, is likely to be responsible for the death of the Tal2 null mice.
Promiscuity and Synergy of Transcription Factors in Development and Tumorigenesis
Genes activated by chromosomal translocations very often encode transcription factors (Cleary, 1991; Rabbitts, 1991) which function via protein-DNA or protein-protein interaction (Rabbitts, 1994) . In addition, many of the genes activated by these chromosomal translocation are normally involved in developmental control but not necessarily in the tissue type in which they cause tumors. TAL2 is an excellent example. It has only been implicated in T cell tumors in man (Baer, 1993) , and yet it has no apparent role in normal hematopoiesis, rather having a vital role in brain development. The opposing functions of TAL2 in normal and malignant development are presumably mediated by its bHLH domain. TAL2 can associate with other HLH proteins (e.g., E47), through this domain, to form DNA-binding complexes which can presumably modulate transcription (Xia et al., 1994) . This dimerization potential might explain both the tropism of TAL2-mediated tumorigenesis and the specific role played by TAL2 in normal brain development. In its normal setting, TAL2 may bind to its appropriate bHLH targets to form transcriptional complexes necessary for proper brain development. By contrast, the enforced expression of TAL2 by tumor-specific chromosomal translocations may disturb the normal network of interacting HLH proteins in a manner that elicits malignant transformation of T-lineage cells. Thus T cell expression of TAL2 may sequester HLH proteins from their normal role and/or it may cause formation of protein complexes which bind DNA and lead to inappropriate gene expression.
Finally, from our current studies and from previous in situ hybridization work (Mori et al., 1999) , it seems that some Tal2 expression occurs in regions in the brain which overlaps with those reported for Tal1 (Sinclair et al., 1999) , including the pretectum, posterior commissure, and tectal commissural fiber tracts. Tal1 and Tal2 are not thought to dimerize with each other for their transcriptional functions. Therefore, it is conceivable that these two bHLH proteins compete for other protein factors in a developmental-stagespecific fashion. A relationship between Tal2 and Pax7 protein is also possible in view of the documented Pax7 expression in the superior colliculus of postnatal mice and Pax7 null mutant mice have a very similar phenotype (Mansouri et al., 1996) . Furthermore, there may be partial redundancy in function between Tal1 and Tal2 (as has been described for Pax3/Pax7, Pax2/Pax5, or Jnk1/Jnk2 where one can partially replace the function of the homologous partner (Urbanek et al., 1997; Mansouri and Gruss, 1998; Kuan et al., 1999) ). This could explain why the Tal2-deficient mice show no severe prenatal abnormalities in developing fiber tracts. Such putative cross-functions in CNS cannot be assessed as yet since Tal1 null mutant mice have early embryonic lethality due to failure of hematopoiesis (Robb et al., 1995 (Robb et al., , 1996 Shivdasani et al., 1995; Porcher et al., 1996) .
